Flannelly Barry P

CIK 00016158423 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001615842

Recent Transactions

50 trades

Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2026-06-15+31,000→ 31,000 total
Sale
INCYTE CORP$INCY
Common Stock
2025-07-16$68.36/sh−1,340→ 35,149 total
Sale
INCYTE CORP$INCY
Common Stock
2025-07-15$69.86/sh−1,192→ 37,630 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-15$68.25/sh−1,141→ 36,489 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-14$69.98/sh−922→ 38,822 total
Sale
INCYTE CORP$INCY
Common Stock
2025-07-03$68.15/sh−10,903→ 39,744 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-02$68.17/sh−9,055→ 50,647 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2025-06-12+24,000→ 24,000 total
Award
INCYTE CORP$INCY
Common Stock
2025-04-01+11,159→ 44,726 total
Award
INCYTE CORP$INCY
Common Stock
2025-04-01+14,976→ 59,702 total
Sale
INCYTE CORP$INCY
Common Stock
2025-03-14$67.88/sh−199→ 52,714 total
Sale
INCYTE CORP$INCY
Common Stock
2025-03-14$67.68/sh−19,147→ 33,567 total
Sale
INCYTE CORP$INCY
Common Stock
2025-03-14$67.85/sh−461→ 52,913 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-01-17+20,144→ 20,144 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-01-15$72.46/sh−3,158→ 53,374 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-12-09$72.11/sh−1,510→ 56,532 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-11-06−1,424→ 0 total
Sale
INCYTE CORP$INCY
Common Stock
2024-11-06$82.00/sh−1,424→ 60,298 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2024-11-06$68.62/sh+2,256→ 61,722 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2024-11-06$72.27/sh+1,424→ 59,466 total
Exercise/Conversion
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-11-06−2,256→ 0 total
Sale
INCYTE CORP$INCY
Common Stock
2024-11-06$78.21/sh−2,256→ 58,042 total
Sale
INCYTE CORP$INCY
Common Stock
2024-07-16$64.19/sh−1,306→ 58,042 total
Award
INCYTE CORP$INCY
Common Stock
2024-07-15+9,925→ 60,459 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-07-15$64.25/sh−1,111→ 59,348 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-07-15+22,205→ 22,205 total
Sale
INCYTE CORP$INCY
Common Stock
2024-07-09$60.00/sh−8,148→ 50,534 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-07-02$59.02/sh−7,695→ 58,682 total
Sale
INCYTE CORP$INCY
Common Stock
2024-06-12$60.00/sh−19,164→ 66,377 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2024-06-07+10,000→ 10,000 total
Award
INCYTE CORP$INCY
Common Stock
2024-02-14+7,377→ 85,080 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-01-18+21,843→ 21,843 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-01-17$61.48/sh−3,675→ 77,703 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2023-07-14+20,275→ 20,275 total
Award
INCYTE CORP$INCY
Common Stock
2023-07-14+9,668→ 81,378 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2023-07-03$62.08/sh−6,304→ 71,710 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2023-06-07+10,000→ 10,000 total
Award
INCYTE CORP$INCY
Common Stock
2023-01-20+4,980→ 77,654 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2023-01-20+19,354→ 19,354 total
Sale
INCYTE CORP$INCY
Common Stock
2022-07-07$79.38/sh−2,873→ 72,674 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2022-07-05$79.25/sh−3,506→ 75,547 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2022-07-02+18,332→ 18,332 total
Award
INCYTE CORP$INCY
Common Stock
2022-07-02+13,529→ 79,053 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2022-06-08+10,000→ 10,000 total
Sale
INCYTE CORP$INCY
Common Stock
2022-04-08$82.96/sh−881→ 66,411 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2022-04-08$68.62/sh+20,516→ 87,808 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2022-04-08$72.27/sh+21,348→ 88,640 total
Sale
INCYTE CORP$INCY
Common Stock
2022-04-08$82.96/sh−1,248→ 65,163 total
Exercise/Conversion
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2022-04-08−21,348→ 0 total
Sale
INCYTE CORP$INCY
Common Stock
2022-04-08$84.00/sh−21,348→ 67,292 total

Companies

Recent Filings

Address

C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR

NEW YORK, NY, 10010

View on SEC.gov